Trial Profile
Post-Liver transplant treatment of Hepatitis C with a combination of sofosbuvir, simeprevir, and ribavirin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Dec 2015 New trial record